Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Mind Medicine (MindMed) Inc. - Common Shares
(NQ:
MNMD
)
12.95
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 30, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mind Medicine (MindMed) Inc. - Common Shares
< Previous
1
2
3
4
5
6
7
8
9
...
34
35
Next >
Psychedelics Break Out Of The Fringe Under RFK Jr’s 2025 Reset — But Did MNMD Or CMPS Own The Year?
↗
December 24, 2025
Regulatory thaw, political backing, and late-stage data are propelling psychedelic drugmakers into the biotech spotlight — with Compass Pathways and Mind Medicine leading the charge.
Via
Stocktwits
Topics
ETFs
MarketBeat’s Top 5 Rated Small-Cap Stocks
↗
December 22, 2025
Via
MarketBeat
MindMed to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 18, 2025
From
Mind Medicine (MindMed) Inc.
Via
Business Wire
MindMed Announces New Employee Inducement Grant
December 15, 2025
From
Mind Medicine (MindMed) Inc.
Via
Business Wire
Earnings Scheduled For November 6, 2025
↗
November 06, 2025
Via
Benzinga
MindMed Announces New Employee Inducement Grants
December 01, 2025
From
Mind Medicine (MindMed) Inc.
Via
Business Wire
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Reports Q3 2025 Earnings Miss Amid Accelerated Clinical Pipeline Spending
↗
November 06, 2025
MindMed reports a wider-than-expected Q3 2025 loss as it accelerates its late-stage clinical trials for MM120, targeting anxiety and depression.
Via
Chartmill
Topics
Earnings
MindMed (MNMD) Q3 2025 Earnings Call Transcript
↗
November 06, 2025
MindMed (MNMD) Q3 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
MindMed Reports Q3 2025 Financial Results and Business Updates
November 06, 2025
From
Mind Medicine (MindMed) Inc.
Via
Business Wire
MindMed to Participate in Upcoming Investor Conferences
November 05, 2025
From
Mind Medicine (MindMed) Inc.
Via
Business Wire
MindMed Announces New Employee Inducement Grant
November 03, 2025
From
Mind Medicine (MindMed) Inc.
Via
Business Wire
Mind Medicine (MindMed) Inc. Announces Closing of Approximately $259 Million Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
November 03, 2025
From
Mind Medicine (MindMed) Inc.
Via
Business Wire
MindMed to Report Q3 2025 Financial Results on November 6, 2025
October 30, 2025
From
Mind Medicine (MindMed) Inc.
Via
Business Wire
Mind Medicine (MindMed) Inc. Announces Pricing of $225 Million Public Offering
October 29, 2025
From
Mind Medicine (MindMed) Inc.
Via
Business Wire
Mind Medicine (MindMed) Inc. Announces Proposed Public Offering
October 29, 2025
From
Mind Medicine (MindMed) Inc.
Via
Business Wire
MindMed Announces New Employee Inducement Grant
October 14, 2025
From
Mind Medicine (MindMed) Inc.
Via
Business Wire
Mind Medicine Analyst Cites Strong Phase 3 Pipeline For Anxiety, Depression
↗
October 13, 2025
Needham starts MindMed at Buy with a $28 target, citing strong Phase 3 prospects for MM120 in anxiety and depression and solid cash position.
Via
Benzinga
The Insider Report: Panic Never Pays
↗
October 11, 2025
Via
Benzinga
MindMed Announces New Employee Inducement Grants
September 22, 2025
From
Mind Medicine Inc.
Via
Business Wire
New MindMed Retrospective Study Presented at Psych Congress 2025 Reveals High Rates of Suicidal Ideation (SI) in Adults with Generalized Anxiety Disorder (GAD)
September 19, 2025
From
Mind Medicine (MindMed) Inc.
Via
Business Wire
MindMed Announces New Employee Inducement Grants
September 08, 2025
From
Mind Medicine Inc.
Via
Business Wire
Journal of the American Medical Association (JAMA) Publishes Results from First-Ever Randomized, Placebo-Controlled Clinical Trial Assessing the Dose-Dependent Efficacy of MM120 (Lysergide D-Tartrate, LSD) in Generalized Anxiety Disorder (GAD)
September 04, 2025
From
Mind Medicine Inc.
Via
Business Wire
MindMed to Participate in September Investor Conferences
August 28, 2025
From
Mind Medicine Inc.
Via
Business Wire
If You'd Invested $1,000 in Mind Medicine (MNMD) Stock 5 Years Ago, Here's How Much You'd Have Today
↗
August 12, 2025
Mind Medicine stock hasn't beaten the market over the last five years, but what comes next?
Via
The Motley Fool
MindMed Announces New Employee Inducement Grants
August 11, 2025
From
Mind Medicine Inc.
Via
Business Wire
MindMed (MNMD) Q2 2025 Earnings Call Transcript
↗
August 11, 2025
Via
The Motley Fool
Topics
Earnings
Initial Public Offering
MindMed Reports Strong Q2 2025 Results
↗
August 11, 2025
Via
The Motley Fool
1 Reason to Buy MindMed (MNMD)
↗
August 07, 2025
The U.S. public and the nation's politicians seem to be coming around to the idea of reforming psychedelic drug laws. Looser restrictions on research would help this company.
Via
The Motley Fool
Topics
Cannabis
Law Enforcement
MindMed (MNMD) Q2 Net Loss Jumps 625%
↗
August 01, 2025
Via
The Motley Fool
Topics
Intellectual Property
MindMed Reports Q2 2025 Financial Results and Business Updates
July 31, 2025
From
Mind Medicine Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
34
35
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
